Senate Committee Raises Alarm Over Rising Drug Prices, Medical College Irregularities
The Senate Standing Committee on National Health Services expressed concern over cartelization in the pharmaceutical sector, which has led to sharp increases in drug prices.
Chairing the meeting, Senator Amir Waliuddin Chishti warned that profiteering by drug manufacturers could undermine government deregulation efforts aimed at making medicines more affordable. He noted that policies might be reviewed if the situation does not improve.
Health Minister Syed Mustafa Kamal assured the committee that a comprehensive assessment report, prepared with stakeholders, would be finalized by September 18.
The committee also highlighted irregularities in the upcoming Medical and Dental Colleges Admission Test (MDCAT) scheduled for October 5, with over 150,000 candidates. Authorities were directed to implement strict monitoring, particularly in Sindh, to prevent paper leaks, with additional safeguards already in place.
Legislative business included the Pakistan Medical and Dental Council (Amendment) Bill, 2025, deferred for further review, and the Mental Health (Amendment) Bill, 2025, which was approved to regulate psychologists. Discussions also covered tighter controls on vaping and outdated tobacco laws.
Senators criticized private medical colleges charging fees above the prescribed Rs. 1.8 million and failing to refund excess payments. The Chairman recommended mandatory audits, while the Minister pledged inspections in Islamabad.
Senator Chishti emphasized that protecting public health remains the government’s top priority and said drug pricing will be revisited after the September report.
